Proteotoxicity and neurodegenerative diseases

65Citations
Citations of this article
111Readers
Mendeley users who have this article in their library.

Abstract

Neurodegenerative diseases are a major burden for our society, affecting millions of people worldwide. A main goal of past and current research is to enhance our understanding of the mechanisms underlying proteotoxicity, a common theme among these incurable and debilitating conditions. Cell proteome alteration is considered to be one of the main driving forces that triggers neurodegeneration, and unraveling the biological complexity behind the affected molecular pathways constitutes a daunting challenge. This review summarizes the current state on key processes that lead to cellular proteotoxicity in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and amyotrophic lateral sclerosis, providing a comprehensive landscape of recent literature. A foundational understanding of how proteotoxicity affects disease etiology and progression may provide essential insight towards potential targets amenable of therapeutic intervention.

Cite

CITATION STYLE

APA

Ruz, C., Alcantud, J. L., Montero, F. V., Duran, R., & Bandres-Ciga, S. (2020, August 2). Proteotoxicity and neurodegenerative diseases. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21165646

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free